glp 1 new indications Blog | Discover Your Weight Journey—Get Informed — Navigate Weight & Metabolic How underwriters should interpret GLP-1

At our practice, we emphasize the importance of consistent use and comprehensive support to help you maintain your results and achieve lasting success

In this complex scenario, the concomitant presence of obesity further increases insulin resistance and exacerbates the clinical presentation of PCOS

Further prospective trials with shot-gun sequencing should be done

[52] Clinical trials shown that GLP-1 receptor agonists improve menstrual regularity , decrease body weight and central adiposity, increase sex hormone-binding globulin levels , and lower free testosterone in overweight and obese women with PCOS

GLP-1 has opposing effects on hepatic lipid accumulation and plasma lipid levels, which has recently broadened its clinical use in pharmacological therapy of metabolic syndrome and steatohepatitis 8,9